Nazem Atassi
Nazem Atassi
Associate Professor of Neurology, Harvard Medical School
Bestätigte E-Mail-Adresse bei mgh.harvard.edu
Titel
Zitiert von
Zitiert von
Jahr
The PRO-ACT database: design, initial analyses, and predictive features
N Atassi, J Berry, A Shui, N Zach, A Sherman, E Sinani, J Walker, ...
Neurology 83 (19), 1719-1725, 2014
1772014
Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [11C]-PBR28
NR Zürcher, ML Loggia, R Lawson, DB Chonde, D Izquierdo-Garcia, ...
NeuroImage: Clinical 7, 409-414, 2015
1652015
Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)
S Paganoni, EA Macklin, A Lee, A Murphy, J Chang, A Zipf, M Cudkowicz, ...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15 (5-6), 453-456, 2014
1332014
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
T Miller, M Cudkowicz, PJ Shaw, PM Andersen, N Atassi, RC Bucelli, ...
New England Journal of Medicine 383 (2), 109-119, 2020
1092020
Transplantation of spinal cord–derived neural stem cells for ALS: analysis of phase 1 and 2 trials
JD Glass, VS Hertzberg, NM Boulis, J Riley, T Federici, M Polak, ...
Neurology 87 (4), 392-400, 2016
1072016
Depression in amyotrophic lateral sclerosis
N Atassi, A Cook, CME Pineda, P Yerramilli-Rao, D Pulley, M Cudkowicz
Amyotrophic Lateral Sclerosis 12 (2), 109-112, 2011
902011
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
M Benatar, J Wuu, PM Andersen, N Atassi, W David, M Cudkowicz, ...
Neurology 90 (7), e565-e574, 2018
822018
ALS biomarkers for therapy development: state of the field and future directions
M Benatar, K Boylan, A Jeromin, SB Rutkove, J Berry, N Atassi, L Bruijn
Muscle & nerve 53 (2), 169-182, 2016
802016
Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
MJ Alshikho, NR Zürcher, ML Loggia, P Cernasov, DB Chonde, DI Garcia, ...
Neurology 87 (24), 2554-2561, 2016
722016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression
MD Weiss, EA Macklin, Z Simmons, AS Knox, DJ Greenblatt, N Atassi, ...
Neurology 86 (16), 1474-1481, 2016
712016
Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia
OH Tam, NV Rozhkov, R Shaw, D Kim, I Hubbard, S Fennessey, N Propp, ...
Cell reports 29 (5), 1164-1177. e5, 2019
662019
Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis
MJ Alshikho, NR Zürcher, ML Loggia, P Cernasov, B Reynolds, ...
Annals of neurology 83 (6), 1186-1197, 2018
532018
Defining SOD1 ALS natural history to guide therapeutic clinical trial design
T Bali, W Self, J Liu, T Siddique, LH Wang, TD Bird, E Ratti, N Atassi, ...
Journal of Neurology, Neurosurgery & Psychiatry 88 (2), 99-105, 2017
422017
A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis
N Atassi, EM Ratai, DJ Greenblatt, D Pulley, Y Zhao, J Bombardier, ...
Amyotrophic Lateral Sclerosis 11 (6), 508-513, 2010
412010
Pseudoreference regions for glial imaging with 11C-PBR28: investigation in 2 clinical cohorts
DS Albrecht, MD Normandin, S Shcherbinin, DW Wooten, AJ Schwarz, ...
Journal of Nuclear Medicine 59 (1), 107-114, 2018
362018
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis
LL Clawson, M Cudkowicz, L Krivickas, BR Brooks, M Sanjak, P Allred, ...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19 (3-4), 250-258, 2018
352018
Improving symptom management for people with amyotrophic lateral sclerosis
K Nicholson, A Murphy, E McDonnell, J Shapiro, E Simpson, J Glass, ...
Muscle & nerve 57 (1), 20-24, 2018
352018
Neuroprotective agents target molecular mechanisms of disease in ALS
Y Zhu, A Fotinos, LLJ Mao, N Atassi, EW Zhou, S Ahmad, Y Guan, ...
Drug discovery today 20 (1), 65-75, 2015
352015
Analysis of start-up, retention, and adherence in ALS clinical trials
N Atassi, P Yerramilli-Rao, J Szymonifka, H Yu, M Kearney, D Grasso, ...
Neurology 81 (15), 1350-1355, 2013
352013
Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis
N Atassi, M Xu, C Triantafyllou, B Keil, R Lawson, P Cernasov, E Ratti, ...
PLoS One 12 (5), e0177680, 2017
342017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20